Polpharma Group acquired Bioceros

Published: 26.07.2016

Bioceros has a high-yield cell line development platform as well as comprehensive process development and analytical capabilities. It will be integrated with Polpharma Group’s Biologics Unit to support the development of biosimilars and other biotechnological drugs for global markets.

“We are very happy to add an industry-leading cell line technology platform, great process development capabilities and a team of senior industry experts to our existing development set-up in Gdansk,” said Markus Sieger, CEO of Polpharma Group. “With Bioceros we will be fully integrated in our biotechnological development capabilities, which is a key success factor for our strategic direction, the development of biosimilars. We look forward to applying this new technology to bring more cost-effective treatment alternatives for serious diseases to patients worldwide.” With this acquisition Polpharma Group will be able to master all steps of the biotech value chain from cell line via process and product development to GMP manufacturing. This is not only highly complementary to the state-of-the-art facilities of Polpharma Biologics in Gdansk, but also accelerates its entry into the CDMO space.

written by: Polpharma Biologics

Let’s collaborate and create quality biologics together.

Get in touch for more information.

We use cookies

Polpharma Biologics uses cookies and other similar technologies (hereinafter: cookies) on its webpages and mobile applications (hereinafter, jointly, Website). The user can manage cookies independently by changing the web browser settings. If you do not consent for your personal data to be collected via cookies, you should change your web browser settings or stop using the Website.

Using the Website without changing the web browser settings indicates your acceptance of the use of cookies by Polpharma. Acceptance of the web browser settings indicates your consent to profiling on the basis of the information contained in cookies. Consent may be withdrawn at any time. Withdrawal of consent does not affect lawfulness of any processing activities carried out under consent before its withdrawal.

For more details see the Cookie Policy.